It was noteworthy that mefloquine hydrochloride, an antimalarial drug, was identified as a novel RAB5A inhibitor and could efficiently disrupt the tumourigenic activity of colorectal cancer stem cells.48 Here, RAB5A is linked to colorectal cancer.